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2006;29:1130–59.Letters to the Editorxercise-Induced
roponin Elevation
ot Necessarily a Benign Phenomenon
n their comprehensive review of exercise-induced cardiac tropo-
in elevation, Shave et al. (1) come to the conclusion that this is a
enign phenomena most likely related to leakage of troponin from
he cardiac myocyte membrane rather than myocyte necrosis—the
sual cause of troponin elevation. In the absence of long-term
ollow-up of elite ultra-endurance athletes, this conclusion should
e viewed with caution. There is increasing evidence that, in some
thletes, participation in multiple extreme endurance events over a
ong period of years can lead to abnormal right ventricular (RV)
nlargement, dysfunction, and—more ominously—potentially le-
hal arrhythmias (2–4). Such athletes are clinically and genetically
istinct from those suffering from familial arrhythmogenic RV
ysplasia/cardiomyopathy (5). An appropriate terminology for
uch individuals is “exercise-induced right ventricular dysplasia”
2–5). A plausible hypothesis for this syndrome is that extreme
ndurance exercise places a strain on the RV that on occasions
eads to myocardial necrosis, albeit small, as reflected in post-
xercise elevated troponin levels. The cumulative effect of repeated
pisodes of necrosis can eventually lead to sufficient fibrosis to
esult in RV dysfunction and to act as a substrate for potentially
ethal arrhythmias. How prevalent exercise-induced RV dysplasia
s and whether there is a genetic predisposition to the condition
emains to be determined.
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eply
e appreciate Dr. Harper’s interest in our recent report (1). Dr.
arper suggests that without reassuring evidence from longitudi-
al studies it is possible that ultra-endurance exercise can produce
variant of right ventricular cardiomyopathy and suggests that the
levated cardiac troponin (cTn) observed after exercise are not
enign. From a historical viewpoint, ultra-endurance events are
ot new. At the turn of the last century walking and running
ontests of several days duration were popular spectator events and
aised concerns similar to those of Dr. Harper, but concerns about
icyclists’, runners’, and rowers’ hearts were never documented (2).
ight ventricular enlargement from endurance activity is not unusual
ut is rather one of the expected adaptations from exercise training.
ndeed, all 4 cardiac chambers enlarge with exercise training, but there
s little evidence of right ventricular dysfunction, except for reversible,
ransient changes after endurance events (3)—which might be related
o a number of factors, such as elevations in heart rate, plasma volume
lterations, or desensitization of beta-adrenoceptors. Furthermore, the
bservations that cTn is elevated after low-intensity exercise such as
alking (4), early during a treadmill marathon (5), and after 30 min
f high-intensity running (6) suggest that cTn elevations are common
ith exercise and not necessarily a product of prolonged effort. Recent
tudies have also shown no relationship between exercise-induced cTn
elease and late gadolinium enhancement with cardiac magnetic
esonance imaging (7) and that, unlike acute coronary syndromes, cTn
apidly returns to baseline after exercise. In combination, such
bservations suggest a benign event. Finally, we would caution Dr.
arper as he has us: in the absence of longitudinal studies, it is
rovocative and premature to suggest that right ventricular problems
bserved in a case series of endurance athletes are produced by their
thletic participation.
